The 60-second version of Indo Rama Synthetics (India) Limited — what it does, how it earns, and who it competes with, before any of the numbers below.
Nothing stands out as clearly deteriorating on the years of data available.
| Metric | FY23 | FY24 | FY25 | FY26 | 3Y CAGR |
|---|---|---|---|---|---|
| Revenue | ₹3,907 Cr | ₹3,696 Cr | ₹4,053 Cr | ₹4,670 Cr | +6.1% |
| EBITDA | ₹58 Cr | -₹43 Cr | ₹194 Cr | ₹325 Cr | +78.2% |
| EBITDA Margin | 1.5% | -1.2% | 4.8% | 7.0% | — |
| PAT (Net Profit) | -₹25 Cr | -₹203 Cr | ₹1 Cr | ₹150 Cr | — |
| EPS | ₹-0.94 | ₹-7.79 | ₹0.05 | ₹5.75 | — |
| ROE | -4.3% | -55.3% | 0.4% | 28.9% | — |
| ROCE | 2.1% | -10.5% | 18.8% | 27.0% | — |
| Total Debt | ₹890 Cr | ₹1,339 Cr | ₹1,136 Cr | ₹1,140 Cr | +8.6% |
| Free Cash Flow | -₹446 Cr | -₹357 Cr | ₹352 Cr | ₹110 Cr | — |
| Company | P/E | ROE |
|---|---|---|
| MARUTI SUZUKI INDIA LTD. | 25.2x | 13.4% |
| TITAN COMPANY LIMITED | 68.5x | 36.7% |
| TRENT LTD | 87.2x | 25.9% |
| AVENUE SUPERMARTS LIMITED | 69.9x | 12.7% |
A reasonable business at a reasonable price. Nothing here is alarming and nothing is compelling, which usually means the decision rests on things this data cannot see — the industry's direction, management's intent, and what else is available to you. 2 high-severity red flags sit above this conclusion and should be read first.